Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in RussiaActive Not Recruiting
Sponsor: AstraZeneca
NSCLC, Non-small-cell Lung Carcinoma
Russia
Sponsor: Georgetown University
Carcinoma, Non-Small Cell Lung
United States
Sponsor: AstraZeneca
Asthma
Austria, Belgium, Canada, Denmark, Germany +4 more
- Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerActive Not Recruiting
Sponsor: The Methodist Hospital Research Institute
Breast Cancer Metastatic · Breast Cancer
United States
Sponsor: AstraZeneca
Breast Cancer
Japan
- Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).Active Not Recruiting
Sponsor: AstraZeneca
Non Small Cell Lung Cancer NSCLC
United States, Brazil, Bulgaria, China, Germany +14 more
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Unresectable Intrahepatic Cholangiocarcinoma
United States
- Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System LymphomaActive Not Recruiting
Sponsor: Washington University School of Medicine
Primary Central Nervous System Lymphoma
United States
Sponsor: University of Pennsylvania
Hereditary Amyloidosis, Transthyretin-Related
United States
- PASS of Paediatric Patients Initiating SelumetinibActive Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis Type 1
Austria, France, Germany, Israel, Italy +5 more
Sponsor: AstraZeneca
Breast Cancer
Russia
Sponsor: UroTrials Company (GmbH)
Prostate Cancer · Biochemical Recurrence of Malignant Neoplasm of Prostate · Non-metastatic Castration-resistant Prostate Cancer · Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Germany
Sponsor: M.D. Anderson Cancer Center
Advanced Intrahepatic Cholangiocarcinoma
United States
- Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and OutcomesCompleted
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
India
Sponsor: Jonsson Comprehensive Cancer Center
Diffuse Large B-Cell Lymphoma · High-grade B-cell Lymphoma · Transformed Lymphoma · Secondary Central Nervous System Lymphoma
United States
- Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma PatientsCompleted
Sponsor: AstraZeneca
Severe Asthma
Colombia, Dominican Republic, India, Kuwait, Oman +3 more
- AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma PatientsActive Not Recruiting
Sponsor: Nader Sanai
Glioblastoma · Glioma · Glioblastoma Multiforme · Glioma, Malignant
United States
Sponsor: Institut Bergonié
Advanced Solid Tumor · Advanced Colorectal Carcinoma · Advanced Soft-tissue Sarcoma · Advanced Pancreatic Adenocarcinoma
France
Sponsor: Institut Bergonié
Non Small Cell Lung Cancer · Advanced Solid Tumor
France
- Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous CarcinomaActive Not Recruiting
Sponsor: M.D. Anderson Cancer Center
Malignant Neoplasms of Female Genital Organs
United States
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
NSCLC (Advanced Non-small Cell Lung Cancer) · HER2
Italy
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease
United States, Canada, China, Germany, South Korea +2 more
- Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Advanced or Metastatic Breast Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: AstraZeneca
Reflux Esophagitis · Gastric Ulcer · Duodenal Ulcer
Japan
Sponsor: AstraZeneca
Advanced Solid Tumours
United States